Voloridge Investment Management
VTYX

Voloridge Investment Management’s Ventyx Biosciences VTYX Stock Holding History

Voloridge Investment Management’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-149,920
Closed -$370K – 1372
2023
Q4 		$370K Buy
+149,920
New +$1.42M ﹤0.01% 1061

Other funds holding VTYX

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Voloridge Investment Management's VTYX Position: Q1 2024 in Review

Voloridge Investment Management sold out of Ventyx Biosciences (VTYX) in Q1 2024, closing a stake of 149,920 shares — an estimated $370K sold.

Voloridge Investment Management first reported a position in VTYX in Q4 2023 and held it in 1 quarter. The position peaked at $370K in Q4 2023. 126 funds tracked by Wall St. Rank hold VTYX as of Q1 2024.

  • Voloridge Investment Management reported no remaining Ventyx Biosciences position as of Q1 2024 after selling out during the quarter.
  • Voloridge Investment Management sold 149,920 Ventyx Biosciences shares in Q1 2024, an estimated $370K.
  • Voloridge Investment Management first reported a position in Ventyx Biosciences in Q4 2023 and held it in 1 quarter.
  • Voloridge Investment Management's Ventyx Biosciences position peaked at $370K in Q4 2023.
  • 126 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2024.

Based on Voloridge Investment Management's 13F filing for Q1 2024, filed 15 May 2024.